These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30604512)

  • 41. The therapeutic potential of monoamine oxidase inhibitors.
    Youdim MB; Edmondson D; Tipton KF
    Nat Rev Neurosci; 2006 Apr; 7(4):295-309. PubMed ID: 16552415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthetic and Natural Monoamine Oxidase Inhibitors as Potential Lead Compounds for Effective Therapeutics.
    Pathak A; Srivastava AK; Singour PK; Gouda P
    Cent Nerv Syst Agents Med Chem; 2016; 16(2):81-97. PubMed ID: 26104056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lights and shadows on monoamine oxidase inhibition in neuroprotective pharmacological therapies.
    Binda C; Milczek EM; Bonivento D; Wang J; Mattevi A; Edmondson DE
    Curr Top Med Chem; 2011 Nov; 11(22):2788-96. PubMed ID: 22039878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of novel monoamine oxidase B inhibitors by structure-based virtual screening.
    Geldenhuys WJ; Darvesh AS; Funk MO; Van der Schyf CJ; Carroll RT
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5295-8. PubMed ID: 20650633
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B.
    Van der Walt MM; Terre'Blanche G; Petzer JP; Petzer A
    Eur J Med Chem; 2017 Jan; 125():1193-1199. PubMed ID: 27855360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
    Legoabe LJ; Petzer A; Petzer JP
    Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human recombinant monoamine oxidase B as reliable and efficient enzyme source for inhibitor screening.
    Novaroli L; Reist M; Favre E; Carotti A; Catto M; Carrupt PA
    Bioorg Med Chem; 2005 Nov; 13(22):6212-7. PubMed ID: 16054369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An updated patent review on monoamine oxidase (MAO) inhibitors.
    Guglielmi P; Carradori S; D'Agostino I; Campestre C; Petzer JP
    Expert Opin Ther Pat; 2022 Aug; 32(8):849-883. PubMed ID: 35638744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversible and irreversible small molecule inhibitors of monoamine oxidase B (MAO-B) investigated by biophysical techniques.
    Rojas RJ; Edmondson DE; Almos T; Scott R; Massari ME
    Bioorg Med Chem; 2015 Feb; 23(4):770-8. PubMed ID: 25600407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, Synthesis and Biological Evaluation of Novel N-Pyridyl-Hydrazone Derivatives as Potential Monoamine Oxidase (MAO) Inhibitors.
    Turan-Zitouni G; Hussein W; Sağlık BN; Tabbi A; Korkut B
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29316677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants.
    Larit F; Elokely KM; Chaurasiya ND; Benyahia S; Nael MA; León F; Abu-Darwish MS; Efferth T; Wang YH; Belouahem-Abed D; Benayache S; Tekwani BL; Cutler SJ
    Phytomedicine; 2018 Feb; 40():27-36. PubMed ID: 29496172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel monoamine oxidase inhibitors, 3-(2-aminoethoxy)-1,2-benzisoxazole derivatives, and their differential reversibility.
    Yoshimi K; Kozuka M; Sakai J; Iizawa T; Shimizu Y; Kaneko I; Kojima K; Iwata N
    Jpn J Pharmacol; 2002 Feb; 88(2):174-82. PubMed ID: 11928718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current place of monoamine oxidase inhibitors in the treatment of depression.
    Shulman KI; Herrmann N; Walker SE
    CNS Drugs; 2013 Oct; 27(10):789-97. PubMed ID: 23934742
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 8-Aryl- and alkyloxycaffeine analogues as inhibitors of monoamine oxidase.
    Strydom B; Bergh JJ; Petzer JP
    Eur J Med Chem; 2011 Aug; 46(8):3474-85. PubMed ID: 21621312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency.
    Tzvetkov NT; Hinz S; Küppers P; Gastreich M; Müller CE
    J Med Chem; 2014 Aug; 57(15):6679-703. PubMed ID: 24955776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of 3-Hydroxy-3-phenacyloxindole Analogues of Isatin as Potential Monoamine Oxidase Inhibitors.
    Tripathi RK; Krishnamurthy S; Ayyannan SR
    ChemMedChem; 2016 Jan; 11(1):119-32. PubMed ID: 26592797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective inhibition of monoamine oxidase A by purpurin, an anthraquinone.
    Lee HW; Ryu HW; Kang MG; Park D; Oh SR; Kim H
    Bioorg Med Chem Lett; 2017 Mar; 27(5):1136-1140. PubMed ID: 28188065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Marine natural products with monoamine oxidase (MAO) inhibitory activity.
    Hong A; Tu LC; Yang I; Lim KM; Nam SJ
    Pharm Biol; 2020 Dec; 58(1):716-720. PubMed ID: 32697127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S; Zheng H; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quercetin and Related Chromenone Derivatives as Monoamine Oxidase Inhibitors: Targeting Neurological and Mental Disorders.
    Dhiman P; Malik N; Sobarzo-Sánchez E; Uriarte E; Khatkar A
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.